$Brainstorm Cell Therapeutics (BCLI.US)$PIII post hoc analys...
$Brainstorm Cell Therapeutics(BCLI.US$PIII post hoc analysis revealed the clinical effectiveness of its NurOwn stem cell Motor Neuron Disease therapy. PIIIb has FDA approval + success can create a 10x catalyst effect.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment